Polyamine effects on antibiotic susceptibility in bacteria

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 2070-2077

  Kwon, Dong Hyeon ^a   Lu, Chung Dar ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZLOCILLIN; BETA LACTAM ANTIBIOTIC; CALCIUM; CARBENICILLIN; CEFALORIDINE; CEFALOTIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLOXACILLIN; ERYTHROMYCIN; IMIPENEM; KANAMYCIN; MAGNESIUM; NOVOBIOCIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; POLYAMINE DERIVATIVE; POLYMYXIN; SODIUM CHLORIDE; SPERMIDINE; SPERMINE; TICARCILLIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ESCHERICHIA COLI; GROWTH INHIBITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYAMINES; SPERMINE; STAPHYLOCOCCUS AUREUS;

EID: 34250176184     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01472-06     Document Type: Article

References (37)

1. Agostinelli, E., G. Arancia, L. D. Vedova, F. Belli, M. Marra, M. Salvi, and A. Toninello. 2004. The biological functions of polyamine oxidation products by amine oxidases: perspectives of clinical applications. Amino Acids 27:347-358.
2. Berger-Bachi, B. 1999. Genetic basis of methicillin resistance in Staphylococcus aureus. Cell. Mol. Life Sci. 56:764-770.
3. Chattopadhyay, M. K., C. W. Tabor, and H. Tabor. 2003. Polyamines protect Escherichia coli cells from the toxic effect of oxygen. Proc. Natl. Acad. Sci. USA 100:2261-2265.
4. Crum, N. F., R. U. Lee, S. A. Thornton, O. C. Stine, M. R. Wallace, C. Barrozo, A. Keefer-Norris, S. Judd, and K. L. Russell. 2006. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am. J. Med. 119:943-951.
5. delaVega, A. L., and A. H. Delcour. 1996. Polyamines decrease Escherichia coli outer membrane permeability. J. Bacteriol. 178:3715-3721.
6. Farinha, M. A., and A. M. Kropinski. 1990. Construction of broad-host-range plasmid vectors for easy visible selection and analysis of promoters. J. Bacteriol. 172:3496-3499.
7. Frazee, B. W., J. Lynn, E. D. Charlebois, L. Lambert, D. Lowery, and F. Perdreau-Remington. 2005. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann. Emerg. Med. 45:311-320.
8. Fuda, C., M. Suvorov, S. B. Vakulenko, and S. Mobashery. 2004. The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J. Biol. Chem. 279:40802-40806.
9. Gambello, M. J., and B. H. Iglewski. 1991. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J. Bacteriol. 173:3000-3009.
10. Gardete, S., S. W. Wu, S. Gill, and A. Tomasz. 2006. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:3424-3434.
11. Gugliucci, A. 2004. Polyamines as clinical laboratory tools. Clin. Chim. Acta 344:23-35.
12. Hancock, R. E., and F. S. Brinkman. 2002. Function of pseudomonas porins in uptake and efflux. Annu. Rev. Microbiol. 56:17-38.
13. Igarashi, K., and K. Kashiwagi. 2006. Polyamine modulon in Escherichia coli: genes involved in the stimulation of cell growth by polyamines. J. Biochem. (Tokyo) 139:11-16.
14. Igarashi, K., and K. Kashiwagi. 2000. Polyamines: mysterious modulators of cellular functions. Biochem. Biophys. Res. Commun. 271:559-564.
15. Jung, I. L., T. J. Oh, and I. G. Kim. 2003. Abnormal growth of polyamine-deficient Escherichia coli mutant is partially caused by oxidative stress-induced damage. Arch. Biochem. Biophys. 418:125-132.
16. Kern, W. V., P. Steinke, A. Schumacher, S. Schuster, H. von Baum, and J. A. Bohnert. 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57:339-343.
17. King, M. D., B. J. Humphrey, Y. F. Wang, E. V. Kourbatova, S. M. Ray, and H. M. Blumberg. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144:309-317.
18. Kwon, D. H., and C. D. Lu. 2006. Polyamines increase antibiotic susceptibility in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1623-1627.
19. Kwon, D. H., and C. D. Lu. 2006. Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother. 50:1615-1622.
20. Lewis, K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem. Sci. 19:119-123.
21. Livermore, D. M. 2000. Antibiotic resistance in staphylococci. Int. J. Antimicrob. Agents 16(Suppl. 1):S3-S10.
22. Livermore, D. M. 1992. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:2046-2048.
23. Lomovskaya, O., and K. A. Bostian. 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem. Pharmacol. 71:910-918.
24. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1993. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175:6299- 6313.
25. Macfarlane, E. L., A. Kwasnicka, and R. E. Hancock. 2000. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146:2543-2554.
26. Macfarlane, E. L., A. Kwasnicka, M. M. Ochs, and R. E. Hancock. 1999. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol. Microbiol. 34:305-316.
27. McPhee, J. B., S. Lewenza, and R. E. Hancock. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
28. Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, and D. A. Talan. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
29. NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. NCCLS, Wayne, PA.
30. NCCLS. 2004. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. M100-S14. NCCLS, Wayne, PA.
31. Nikaido, H. 1996. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178:5853-5859.
32. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
33. Pai, H., J. Kim, J. Kim, J. H. Lee, K. W. Choe, and N. Gotoh. 2001. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 45:480-484.
34. Schweizer, H. D. 1993. Small broad-host-range gentamycin resistance gene cassettes for site-specific insertion and deletion mutagenesis. BioTechniques 15:831-834.
35. Stibitz, S., W. Black, and S. Falkow. 1986. The construction of a cloning vector designed for gene replacement in Bordetella pertussis. Gene 50:133-140.
36. White, R. L., D. S. Burgess, M. Manduru, and J. A. Bosso. 1996. Comparison of three different in vitro methods of detecting synergy: time-kill, checker-board, and E test. Antimicrob. Agents Chemother. 40:1914-1918.
37. Wu, C. Y., J. Hoskins, L. C. Blaszczak, D. A. Preston, and P. L. Skatrud. 1992. Construction of a water-soluble form of penicillin-binding protein 2a from a methicillin-resistant Staphylococcus aureus isolate. Antimicrob. Agents Chemother. 36:533-539.